These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21501510)

  • 1. Dual diagnosis clients' treatment satisfaction - a systematic review.
    Schulte SJ; Meier PS; Stirling J
    BMC Psychiatry; 2011 Apr; 11():64. PubMed ID: 21501510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual diagnosis competency among addiction treatment staff: Training levels, training needs and the link to retention.
    Schulte SJ; Meier PS; Stirling J; Berry M
    Eur Addict Res; 2010; 16(2):78-84. PubMed ID: 20110712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment approaches for dual diagnosis clients in England.
    Schulte SJ; Meier PS; Stirling J; Berry M
    Drug Alcohol Rev; 2008 Nov; 27(6):650-8. PubMed ID: 18830860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental illness and substance use: an Australian perspective.
    Munro I; Edward KL
    Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia.
    Kingston REF; Marel C; Mills KL
    Drug Alcohol Rev; 2017 Jul; 36(4):527-539. PubMed ID: 27786426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment programmes for people with both severe mental illness and substance misuse.
    Ley A; Jeffery DP; McLaren S; Siegfried N
    Cochrane Database Syst Rev; 2000; (4):CD001088. PubMed ID: 11034697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment programmes for people with both severe mental illness and substance misuse.
    Ley A; Jeffery DP; McLaren S; Siegfried N
    Cochrane Database Syst Rev; 2000; (2):CD001088. PubMed ID: 10796588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual diagnosis and psychosocial interventions--introduction and commentary.
    Thylstrup B; Johansen KS
    Nord J Psychiatry; 2009; 63(3):202-8. PubMed ID: 19034725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining dual diagnosis of mental illness and substance misuse: some methodological issues.
    Todd J; Green G; Harrison M; Ikuesan BA; Self C; Baldacchino A; Sherwood S
    J Psychiatr Ment Health Nurs; 2004 Feb; 11(1):48-54. PubMed ID: 14723639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which substance abuse treatment facilities offer dual diagnosis programs?
    Mojtabai R
    Am J Drug Alcohol Abuse; 2004 Aug; 30(3):525-36. PubMed ID: 15540491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dual diagnosis in psychoactive substance abusing or dependent persons].
    Błachut M; Badura-Brzoza K; Jarzab M; Gorczyca P; Hese RT
    Psychiatr Pol; 2013; 47(2):335-52. PubMed ID: 23888766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Mueser KT; Drake RE
    Drug Alcohol Rev; 2004 Dec; 23(4):471-81. PubMed ID: 15763752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with dual diagnosis in secondary psychiatric care.
    Luoto KE; Koivukangas A; Lassila A; Kampman O
    Nord J Psychiatry; 2016 Aug; 70(6):470-6. PubMed ID: 27049473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Client-Provider relationship in comprehensive substance abuse treatment: differences in residential and nonresidential settings.
    Shin HC; Marsh JC; Cao D; Andrews CM
    J Subst Abuse Treat; 2011 Dec; 41(4):335-46. PubMed ID: 21871770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-occurrence of substance use related and mental health problems in the Finnish social and health care system.
    Kuussaari K; Hirschovits-Gerz T
    Scand J Public Health; 2016 Mar; 44(2):202-8. PubMed ID: 26620364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting therapeutic alliance in clients with psychosis and substance misuse.
    Barrowclough C; Meier P; Beardmore R; Emsley R
    J Nerv Ment Dis; 2010 May; 198(5):373-7. PubMed ID: 20458201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Client Satisfaction Questionnaire-8: Psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment.
    Kelly PJ; Kyngdon F; Ingram I; Deane FP; Baker AL; Osborne BA
    Drug Alcohol Rev; 2018 Jan; 37(1):79-86. PubMed ID: 28480521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders.
    Xie H; McHugo GJ; Fox MB; Drake RE
    Psychiatr Serv; 2005 Oct; 56(10):1282-7. PubMed ID: 16215196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.